Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal Tumors

NCT03571438 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT03571438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03571438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal Tumors
Lead sponsor
University Hospital, Grenoble
Phase
Not applicable
Overall status
Unknown status
Start date
October 16, 2017
Completion date
September 30, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer